Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3699969011 | Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3699970012 | Naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
108316801000001113 | Naloxone hydrochloride 0.5 mg and pentazocine hydrochloride 50 mg oral tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Is a | Product containing pentazocine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has active ingredient | Opiate agonist-antagonist | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has active ingredient | Pentazocine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Is a | Product containing naloxone hydrochloride and pentazocine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has active ingredient | Naloxone hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has active ingredient | Substance with chelating agent mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has active ingredient | Pentazocine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has active ingredient | Central nervous system agent | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has active ingredient | Opiate agonist-antagonist | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Is a | Product containing naloxone in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Is a | Product containing pentazocine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has basis of strength substance | Pentazocine hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has basis of strength substance | Naloxone hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has active ingredient | Naloxone hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has basis of strength substance | Naloxone hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 0.5 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has active ingredient | Pentazocine hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has basis of strength substance | Pentazocine hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has precise active ingredient | Pentazocine hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has precise active ingredient | Naloxone hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Is a | Product containing naloxone and pentazocine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | microgram | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Is a | Product containing only naloxone and pentazocine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has precise active ingredient | Pentazocine hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet | Has precise active ingredient | Naloxone hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets